[Superiority of iodixanole vs hypoosmolar contrasts in the prevention of contrast-induced nephropathy in patients at risk: myth or reality?]

Med Clin (Barc). 2010 Sep 11;135(8):362-4. doi: 10.1016/j.medcli.2010.03.029. Epub 2010 Jun 16.
[Article in Spanish]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Contrast Media / adverse effects*
  • Humans
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / prevention & control*
  • Osmolar Concentration
  • Risk Factors
  • Triiodobenzoic Acids*

Substances

  • Contrast Media
  • Triiodobenzoic Acids
  • iodixanol